C
Casgevy
Analyzing
Extracting target signal
Casgevy
Extracting target signal
Casgevy
Arcmira media summary
Browse Casgevy reviews, demos & launch coverage — 2 indexed from Core Memory Podcast, updated Jan 2026.
The first FDA-approved CRISPR-based therapy for sickle cell anemia.
Arcmira tracks 2 indexed media appearances or mentions for Casgevy, tied to source videos, channels, and transcript-derived context.
Arcmira uses indexed YouTube videos and transcripts. Representative source evidence on this page includes "The Present And Future Of Gene Editing - EP 54 Jennifer Doudna" with transcript-derived context and links when available.
Casgevy is connected to Preventive medicine, Humanoid robots, Germline Editing in Arcmira's media graph.
2
Mentions
4.9K
Views
The trendline is visible, but the dated evidence behind Casgevy is in the premium layer.
“The first FDA-approved CRISPR-based therapy for sickle cell anemia.”